
Hologic maintains a healthy pace of acquisitions ..... should provide a buffer in the near term, Hologic offers a number of other high-ticket ..... weakness or tight credit environments. Hologic must innovate and protect its intellectual
Hologic HOLX posted second-quarter results mostly in line with our expectations on ..... headwinds, our positive thesis remains intact and we continue to view Hologic as an attractive investment opportunity for the long term.
Hologic ( HOLX ) Q2 2013 Earnings Call May 06, 2013 5:00 pm ET Executives Deborah ..... br/><a href='http://seekingalpha.com/article/1407621- hologic -management-discusses-q2-2013-results-earnings-call-transcript
Hologic ( HOLX ): Q1 EPS of $0.35 beats by $0.01 . Revenue of $619.1M misses by $20.43M . ( PR ) Post your comment!
Good day everyone and welcome to the Hologic Incorporated Second Quarter Fiscal 2013 Earnings Conference ..... you, Jessica. Good afternoon and thank for joining us for Hologic 's second quarter fiscal 2013 earnings call. The replay of
s close: ALNY , AMTG , APC , ARRY , BSFT , CECO , CHUY , DPM , ENOC , EOG , FSLR , FST , FTR , GDP , GSM , GWAY , HIMX , HOLX , LGCY , MELI , MKTG , MMLP , MR , NOG , NRP , OTTR , PAA , PEGA , PNG , RKUS , SGY , SMG , SNTS , STAG , VNO , WMS Post your
s close: ALNY , AMTG , APC , ARRY , BSFT , CECO , CHUY , DPM , ENOC , EOG , FSLR , FST , FTR , GDP , GSM , GWAY , HIMX , HOLX , LGCY , MELI , MKTG , MMLP , MR , NOG , NRP , OTTR , PAA , PEGA , PNG , RKUS , SGY , SMG , SNTS , STAG , VNO , WMS Post your
After-hours top gainers, as of 5:15 p.m.: PLCM +4% . WLK +4% . IM +4% . ANV +4% . RES +4% . After-hours top losers: USLV -4% . PTIE -3% . HOLX -3% . ARP -2% . RSH -2% . Post your comment!
artificially boost earnings per share while actually decreasing economic earnings (see " Earnings Accretion is a Myth: Sell HOLX "). While that is an issue here, an even bigger issue is the way this merger has boosted ESRX's accounting book value six
By Paul Nouri : Long term investors are familiar with the chart below and the story that goes with it, but for those that are not familiar, I will go into a brief explanation. From the time Quest Diagnostics ( DGX ) went public in 1996 to 2006, investors were rewarded with a compound annual gain of